GYNOREST Drug Patent Profile
✉ Email this page to a colleague
When do Gynorest patents expire, and what generic alternatives are available?
Gynorest is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in GYNOREST is dydrogesterone. There is one drug master file entry for this compound. Additional details are available on the dydrogesterone profile page.
Summary for GYNOREST
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Patent Applications: | 1,844 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GYNOREST at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GYNOREST
US Patents and Regulatory Information for GYNOREST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solvay | GYNOREST | dydrogesterone | TABLET;ORAL | 017388-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Solvay | GYNOREST | dydrogesterone | TABLET;ORAL | 017388-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |